{"id":"fenproporex","rwe":[{"pmid":"40272623","year":"2025","title":"A simple method for the determination of stimulant substances in postmortem blood: development, validation, and application in nearly 1000 forensic cases.","finding":"","journal":"Forensic toxicology","studyType":"Clinical Study"},{"pmid":"34050658","year":"2022","title":"Determination of Drugs of Abuse in Hair by LC-MS-MS: Application to Suicide Attempts Investigation.","finding":"","journal":"Journal of analytical toxicology","studyType":"Clinical Study"},{"pmid":"32771886","year":"2020","title":"Validation of an analytical method for the simultaneous determination of 16 drugs and metabolites in hair in the context of driving license granting.","finding":"","journal":"Forensic science international","studyType":"Clinical Study"},{"pmid":"31962207","year":"2020","title":"Hollow-fibre liquid-phase microextraction and gas chromatography-mass spectrometric determination of amphetamines in whole blood.","finding":"","journal":"Journal of chromatography. B, Analytical technologies in the biomedical and life sciences","studyType":"Clinical Study"},{"pmid":"31729302","year":"2020","title":"Meta-analysis and Approach of the Real Impact of Anorexigenic Drugs in the Obesity in Humans: The Last Five Years of the Randomized Studies.","finding":"","journal":"Current diabetes reviews","studyType":"Clinical Study"}],"tags":[{"label":"fenproporex","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"},{"label":"Obesity","category":"indication"}],"phase":"marketed","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=FENPROPOREX","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:07:04.713095+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:07:10.787818+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=FENPROPOREX","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:07:11.111601+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL2105566/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:07:11.893285+00:00"}},"allNames":"desobesi","offLabel":[],"synonyms":["fenproporex hydrochloride","fenproporex chlorhydrate","fenproporex","cyanoethylamphetamine","desobesi","ferrproporex"],"timeline":[],"approvals":[],"brandName":"Desobesi","ecosystem":[{"indication":"Obesity","otherDrugs":[{"name":"amfetamine","slug":"amfetamine","company":"Ucb Inc"},{"name":"benzphetamine","slug":"benzphetamine","company":"Pharmacia And Upjohn"},{"name":"bupropion","slug":"bupropion","company":"Glaxosmithkline"},{"name":"chlorphentermine","slug":"chlorphentermine","company":"Parke Davis"}],"globalPrevalence":890000000}],"mechanism":{"modality":"Small Molecule","drugClass":"fenproporex","explanation":"","oneSentence":"","technicalDetail":"Fenproporex is a dopamine reuptake inhibitor that acts on the dopamine transporter (DAT) to increase extracellular dopamine levels, thereby modulating appetite and reward pathways."},"commercial":{"revenueYear":2025,"annualRevenue":172,"revenueSource":"Teva 2026-02-03 (verified from SEC filing)","revenueCurrency":"USD","revenueConfidence":"high"},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/1161","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=FENPROPOREX","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T11:25:54.478973","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:07:13.558602+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[],"genericName":"fenproporex","indications":{"approved":[{"name":"Obesity","source":"DrugCentral","snomedId":414916001,"regulator":"FDA","usPrevalence":100000000,"globalPrevalence":890000000,"prevalenceMethod":"curated","prevalenceSource":"WHO, 2024"}],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"NDDF":"005326","UNII":"W0194S5FOA","CHEBI":"CHEBI:134837","INN_ID":"2176","RXNORM":"236528","UMLSCUI":"C0060194","chemblId":"CHEMBL2105566","ChEMBL_ID":"CHEMBL2105566","KEGG_DRUG":"D07947","DRUGBANK_ID":"DB01550","PUBCHEM_CID":"61810","SNOMEDCT_US":"96242001","SECONDARY_CAS_RN":"16359-54-9","MESH_SUPPLEMENTAL_RECORD_UI":"C026013"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":74,"therapeuticAreas":["Metabolic"],"_revenueScrapedAt":"2026-03-31 14:09:35.487336+00","biosimilarFilings":[],"recentPublications":[{"date":"2025 Jul","pmid":"40272623","title":"A simple method for the determination of stimulant substances in postmortem blood: development, validation, and application in nearly 1000 forensic cases.","journal":"Forensic toxicology"},{"date":"2022 May 20","pmid":"34050658","title":"Determination of Drugs of Abuse in Hair by LC-MS-MS: Application to Suicide Attempts Investigation.","journal":"Journal of analytical toxicology"},{"date":"2020 Oct","pmid":"32771886","title":"Validation of an analytical method for the simultaneous determination of 16 drugs and metabolites in hair in the context of driving license granting.","journal":"Forensic science international"},{"date":"2020 Feb 15","pmid":"31962207","title":"Hollow-fibre liquid-phase microextraction and gas chromatography-mass spectrometric determination of amphetamines in whole blood.","journal":"Journal of chromatography. B, Analytical technologies in the biomedical and life sciences"},{"date":"2020","pmid":"31729302","title":"Meta-analysis and Approach of the Real Impact of Anorexigenic Drugs in the Obesity in Humans: The Last Five Years of the Randomized Studies.","journal":"Current diabetes reviews"}],"companionDiagnostics":[],"genericManufacturerList":[],"status":"withdrawn","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:07:13.558602+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":true,"safety":false,"trials":false,"score":1}}